PROCEPT BioRobotics Corporation logo PRCT - PROCEPT BioRobotics Corporation

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 11
HOLD 3
SELL 1
STRONG
SELL
0
| PRICE TARGET: $42.40 DETAILS
HIGH: $62.00
LOW: $30.00
MEDIAN: $35.00
CONSENSUS: $42.40
UPSIDE: 52.22%
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Revenue
Revenue 83.1 76.4 83.3 79.2 69.2 68.2 58.4 53.4 44.5 43.6 35.1 33.1 24.4 23.8 20.3 16.7 14.2 10.1 8.7 8.5 7.2 3.2 2.1 1.2 1.2
Cost of Revenue 29.2 30.1 30.9 29.0 25.0 24.6 21.5 21.9 19.5 22.3 16.2 14.7 11.9 13.1 10.1 8.2 6.5 5.6 4.4 4.9 3.7 2.8 2.1 2.0 2.0
Gross Profit 53.9 46.3 52.4 50.2 44.2 43.7 36.9 31.5 25.0 21.3 18.9 18.4 12.5 10.7 10.2 8.5 7.7 4.5 4.2 3.6 3.5 0.5 (0.0) (0.8) (0.8)
Operating Expenses
R&D Expenses 21.5 19.1 16.6 16.0 16.4 15.1 16.6 17.5 13.1 14.5 11.6 11.6 10.7 9.7 7.6 6.7 5.0 5.1 4.9 4.5 4.5 4.5 3.9 3.9 3.9
SG&A Expenses 65.1 58.3 59.0 56.3 55.2 48.3 42.7 40.8 39.6 36.3 32.9 32.4 30.1 26.0 24.8 19.7 18.4 16.3 12.1 12.3 10.3 9.1 7.1 0 0
Other Expenses 0 0 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7.0 7.0
Operating Expenses 86.6 77.4 75.6 72.3 71.6 63.4 59.3 58.3 52.7 50.8 44.5 44.1 40.9 35.7 32.3 26.4 23.4 21.3 17.0 16.8 14.9 13.7 10.9 11.0 11.0
Operating Income
Operating Income (32.6) (31.0) (23.2) (22.2) (27.4) (19.7) (22.4) (26.8) (27.6) (29.6) (25.6) (25.6) (28.4) (25.0) (22.1) (17.9) (15.7) (16.8) (12.8) (13.2) (11.3) (13.2) (11.0) (11.8) (11.8)
Interest Expense 0.8 0.9 0.9 0.9 0.9 1.0 1.1 1.0 1.0 1.1 1.0 1.0 0.9 0.9 1.5 1.4 1.4 1.4 1.5 1.4 1.5 1.8 1.4 0 0
Interest Income 0 0 0 0 0 3.3 2.6 2.2 2.7 3.5 2.0 1.3 0.8 1.5 0.9 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 1.0
Profitability
EBITDA (30.9) (29.3) (21.6) (20.6) (26.0) (16.4) (18.5) (23.3) (23.7) (25.1) (22.5) (23.7) (26.8) (26.6) (20.5) (17.0) (14.9) (16.1) (11.8) (12.3) (10.4) (12.8) (9.9) (11.1) (11.1)
EBIT (32.6) (31.0) (23.2) (22.2) (27.4) (17.9) (19.8) (24.6) (24.9) (26.4) (23.6) (24.3) (27.6) (27.3) (21.2) (17.7) (15.7) (16.9) (12.6) (13.1) (11.4) (13.5) (10.6) (11.8) (11.8)
Income Before Tax (31.6) (29.7) (21.4) (19.6) (24.7) (18.9) (21.0) (25.6) (26.0) (27.5) (24.6) (25.3) (28.5) (28.2) (22.6) (19.2) (17.2) (18.3) (14.1) (14.6) (12.8) (15.3) (12.0) (12.9) (12.9)
Income Tax Expense 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (31.6) (29.8) (21.4) (19.6) (24.7) (18.9) (21.0) (25.6) (26.0) (27.5) (24.6) (25.3) (28.5) (28.2) (22.6) (19.2) (17.2) (18.3) (14.1) (14.6) (12.8) (15.3) (12.0) (12.9) (12.9)
Per Share Data
EPS (Basic) -0.56 -0.53 -0.38 -0.35 -0.45 -0.35 -0.40 -0.50 -0.51 -0.54 -0.51 -0.56 -0.63 -0.63 -0.51 -0.43 -0.39 -0.42 -0.33 -0.35 -0.36 -0.43 -0.34 -4.56 -4.56
EPS (Diluted) -0.56 -0.53 -0.38 -0.35 -0.45 -0.35 -0.40 -0.50 -0.51 -0.54 -0.51 -0.56 -0.63 -0.63 -0.51 -0.43 -0.39 -0.42 -0.33 -0.35 -0.36 -0.43 -0.34 -4.56 -4.56
Shares Outstanding 56.5 56.1 55.7 55.4 54.9 53.8 52.0 51.6 51.0 50.6 48.3 45.2 45.1 44.8 44.6 44.3 43.9 43.5 42.4 41.2 35.1 35.1 35.1 2.8 2.8
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4
Current Assets
Cash & Cash Equivalents 245.6 286.5 294.3 302.7 316.2 333.7 196.8 214.1 225.6 257.2 287.9 150.5 181.7 222.6 249.2 269.8 284.3 304.3 320.5 159.2 100.1 100.1
Short-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Receivables 96.4 83.5 84.5 80.8 79.3 83.5 69.0 58.9 56.1 48.4 34.6 33.2 20.6 15.3 12.8 10.9 7.0 4.5 6.4 5.1 0 1.5
Inventory 77.5 70.7 66.7 67.0 62.3 56.2 50.9 43.9 41.6 39.8 42.2 42.6 38.9 28.5 22.4 13.8 13.2 13.1 10.7 10.7 0 7.5
Other Current Assets 8.5 9.6 8.7 7.1 7.6 8.5 6.3 5.0 5.9 5.2 4.0 3.7 4.3 6.2 4.5 3.9 0.7 3.4 0.6 0.3 (100.1) 0.7
Total Current Assets 428.0 450.4 454.2 457.7 465.4 481.8 323.0 321.9 329.2 350.6 368.7 230.0 245.6 272.6 288.9 298.3 308.0 326.2 339.5 176.5 0 110.3
Non-Current Assets
Property, Plant & Equipment 48.9 47.9 47.9 46.9 46.7 45.6 45.9 47.3 48.4 49.0 47.7 37.9 34.4 32.1 29.5 6.9 7.4 8.3 9.4 10.5 0 12.9
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0.6 0.7 0.7 0.8 0.9 0.9 1 1.1 1.1 1.2 1.3 1.3 1.4 1.5 1.5 1.6 1.7 1.8 1.8 1.9 0 2.0
Long-Term Investments 0 0 6.3 5.8 5.1 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.8 3.8 3.8 0.8 0.8 0.8 0 0
Other Non-Current Assets 9.5 9.1 2.4 1.9 1.4 2.6 1.3 1.1 1.2 0.9 0.4 0.1 0.1 0.1 0.2 0.3 0 0 0 0.9 0 0.8
Total Non-Current Assets 59.0 57.7 57.3 55.4 54.0 52.2 51.2 52.5 53.7 54.1 52.5 42.4 38.9 36.7 35.1 12.6 12.9 10.9 12.0 14.1 0 15.7
Total Assets 487.1 508.1 511.5 513.1 519.4 534.0 374.1 374.4 382.9 404.7 421.1 272.4 284.5 309.3 324.0 310.9 320.9 337.0 351.5 190.6 0 126.0
Current Liabilities
Account Payables 18.9 17.3 11.1 11.8 14.8 10.0 15.1 9.9 10.1 13.5 13.6 10.0 10.3 9.4 6.3 3.3 2.6 2.0 3.6 3.3 0 1.2
Short-Term Debt 0 0 2.1 2.1 2.0 1.9 1.8 1.8 1.7 1.7 1.7 2.4 3.0 2.1 2.5 2.3 2.2 2.1 2.0 2.0 0 4.6
Deferred Revenue 13.7 13.0 10.7 9.9 9.8 9.6 8.0 6.6 5.9 5.7 5.0 4.7 3.9 2.9 2.3 1.9 1.4 1.0 0.8 0.7 0 0.2
Other Current Liabilities 31.1 35.5 8.2 9.7 10.5 10.1 9.9 9.7 9.5 8.2 7.8 8.9 7.8 7.5 5.9 4.3 4.0 4.6 2.8 3.8 0 5.7
Total Current Liabilities 63.6 65.8 53.9 49.7 52.1 53.1 53.6 42.8 38.6 45.9 41.4 35.9 32.5 35.3 27.4 18.6 14.8 16.2 14.2 13.8 0 14.5
Non-Current Liabilities
Long-Term Debt 51.7 51.6 51.6 51.5 51.5 51.5 51.4 51.4 51.4 51.3 51.3 51.3 51.2 51.2 50.7 50.5 50.3 50.0 49.8 49.5 0 44.4
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 24.1 24.8 0.6 0.2 0.3 0.3 0.5 0.5 0.5 0.5 1.9 1.8 1.8 1.8 1.8 1.8 1.7 1.7 1.7 330.6 (61.0) 245.8
Total Non-Current Liabilities 75.8 76.4 77.4 77.5 78.2 78.7 79.3 79.7 80.2 78.0 80.4 80.6 78.8 77.0 75.9 53.1 53.4 53.7 54.0 383.1 (61.0) 294.3
Total Liabilities 139.4 142.2 131.3 127.3 130.2 131.8 132.9 122.6 118.9 124.0 121.8 116.5 111.3 112.3 103.3 71.7 68.2 69.9 68.2 396.9 (61.0) 308.9
Stockholders' Equity
Common Stock 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Retained Earnings (673.2) (641.6) (611.7) (590.3) (570.7) (546.0) (527.1) (506.2) (480.5) (454.6) (427.1) (402.4) (377.2) (348.7) (320.5) (297.9) (278.7) (261.5) (243.2) (229.1) 0 (201.7)
Accumulated Other Comprehensive Income 0 0 0.0 (0.1) 0.2 0.1 (0.0) (0.0) 0.1 0.1 (0.0) (0.0) 0.0 (0.0) 0.2 0.0 (0.1) (0.1) (0.0) (0.0) (182.9) (0.0)
Total Stockholders' Equity 347.7 365.9 380.3 385.8 389.2 402.2 241.2 251.8 264.0 280.8 299.4 155.9 173.1 197.1 220.8 239.2 252.8 267.1 283.3 (206.3) 61.0 (182.9)
Total Liabilities & Equity 487.1 508.1 511.5 513.1 519.4 534.0 374.1 374.4 382.9 404.7 421.1 272.4 284.5 309.3 324.0 310.9 320.9 337.0 351.5 190.6 0 126.0
Debt Metrics
Total Debt 51.7 51.6 78.9 79.4 79.8 80.2 80.6 81.0 81.4 79.2 79.7 80.8 80.0 77.3 76.6 53.6 53.9 54.1 54.3 54.5 0 54.8
Net Debt (194.0) (234.9) (215.4) (223.3) (236.4) (253.5) (116.1) (133.1) (144.2) (178.0) (208.1) (69.7) (101.7) (145.3) (172.6) (216.2) (230.4) (250.2) (266.1) (104.7) (100.1) (45.4)
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Operating Activities
Net Income (31.6) (29.8) (21.4) (19.6) (24.7) (18.9) (21.0) (25.6) (26.0) (27.5) (24.6) (25.3) (28.5) (28.2) (22.6) (19.2) (17.2) (18.3) (14.1) (14.6) (12.8) (15.3) (12.0) (12.9) (12.9)
Depreciation & Amortization 1.7 1.7 1.6 1.6 1.5 1.5 1.3 1.3 1.2 1.3 1.1 0.6 0.8 0.7 0.7 0.7 0.8 0.8 0.8 0.8 0.9 0.7 0.7 0.7 0.7
Stock-Based Compensation 13.1 10.8 14.5 12.2 10.1 9.1 8.5 8.0 6.3 5.0 5.3 5.1 3.7 2.9 3.2 2.7 1.6 1.5 0.9 0.7 0.7 0.6 0.6 0.5 0.5
Change in Working Capital (21.9) 8.0 (2.4) (9.5) (4.3) (25.0) (8.5) (0.2) (13.7) (3.5) (1.1) (8.8) (12.7) (4.8) (2.1) (1.3) (3.3) (0.4) (0.1) (0.6) (3.6) (0.1) 0.2 0.2 0.2
Other Non-Cash Items 0.6 (1.1) 1.0 0.3 0.5 0.9 0.8 0.8 (0.1) (0.1) 0.4 0.0 0.7 4.2 1.0 (0.1) (0.1) 0.1 (0.1) (0.1) (0.4) (0.0) (0.1) (0.3) (0.3)
Operating Cash Flow (38.1) (10.3) (6.6) (15.0) (17.0) (32.4) (18.8) (15.7) (32.3) (24.8) (18.9) (28.3) (35.9) (25.2) (19.9) (17.1) (18.2) (16.5) (12.8) (12.9) (15.2) (13.4) (10.9) (12.0) (12.0)
Investing Activities
Capital Expenditure (2.9) (1.9) (2.9) (2.8) (1.8) (1.2) (0.2) (1.0) (1.9) (8.7) (5.8) (5.4) (5.3) (0.9) (1.5) (0.2) (0.1) (0.3) (0.1) (0.1) (0.0) (0.0) (0.0) (0.1) (0.1)
Acquisitions 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sales/Maturities of Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Investing Activities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Investing Cash Flow (2.9) (1.9) (2.9) (2.8) (1.8) (1.2) (0.2) (1.0) (1.9) (8.7) (5.8) (5.4) (5.3) (0.9) (1.5) (0.2) (0.1) (0.3) (0.1) (0.1) (0.0) (0.0) (0.0) (0.1) (0.1)
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 1.1 4.4 0 0 0 5.3 2.6 2.9 162.1 2.4 0.4 (1.3) 0.8 2.9 1.3 0.7 174.1 86.1 1.2 0.2 2.8 13.6 13.6
Financing Cash Flow 0.2 4.4 1.1 4.4 1.3 170.5 1.7 5.3 2.6 2.9 162.1 2.4 0.4 (1.3) 0.8 2.9 1.3 0.6 174.1 86.1 1.2 0.2 79.2 13.6 13.6
Cash Position
Net Change in Cash (40.9) (7.8) (8.4) (13.5) (17.5) 137.0 (17.3) (11.5) (31.6) (30.6) 137.4 (31.3) (40.9) (27.4) (20.6) (14.5) (17.0) (16.2) 161.3 73.1 (14.0) (13.2) 68.3 45.9 1.6
Cash at Beginning 289.5 297.3 305.8 319.2 336.8 199.8 217.1 228.6 260.3 290.9 153.5 184.8 225.7 253.0 273.6 288.1 305.1 321.3 160.0 86.9 100.9 114.1 45.9 0 0
Cash at End 248.7 289.5 297.3 305.8 319.2 336.8 199.8 217.1 228.6 260.3 290.9 153.5 184.8 225.7 253.0 273.6 288.1 305.1 321.3 160.0 86.9 100.9 114.1 45.9 1.6
Free Cash Flow (41.0) (12.2) (9.5) (17.8) (18.8) (33.6) (19.0) (16.8) (34.2) (33.5) (24.7) (33.7) (41.3) (26.0) (21.4) (17.3) (18.3) (16.8) (12.9) (13.0) (15.2) (13.5) (11.0) (12.1) (12.1)
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Income Statement
Revenue 83.1 76.4 83.3 79.2 69.2 68.2 58.4 53.4 44.5 43.6 35.1 33.1 24.4 23.8 20.3 16.7 14.2 10.1 8.7 8.5 7.2 3.2 2.1 1.2 1.2
Gross Profit 53.9 46.3 52.4 50.2 44.2 43.7 36.9 31.5 25.0 21.3 18.9 18.4 12.5 10.7 10.2 8.5 7.7 4.5 4.2 3.6 3.5 0.5 (0.0) (0.8) (0.8)
Operating Income (32.6) (31.0) (23.2) (22.2) (27.4) (19.7) (22.4) (26.8) (27.6) (29.6) (25.6) (25.6) (28.4) (25.0) (22.1) (17.9) (15.7) (16.8) (12.8) (13.2) (11.3) (13.2) (11.0) (11.8) (11.8)
Net Income (31.6) (29.8) (21.4) (19.6) (24.7) (18.9) (21.0) (25.6) (26.0) (27.5) (24.6) (25.3) (28.5) (28.2) (22.6) (19.2) (17.2) (18.3) (14.1) (14.6) (12.8) (15.3) (12.0) (12.9) (12.9)
EPS (Diluted) -0.56 -0.53 -0.38 -0.35 -0.45 -0.35 -0.40 -0.50 -0.51 -0.54 -0.51 -0.56 -0.63 -0.63 -0.51 -0.43 -0.39 -0.42 -0.33 -0.35 -0.36 -0.43 -0.34 -4.56 -4.56
Balance Sheet
Cash & Equivalents 245.6 286.5 294.3 302.7 316.2 333.7 196.8 214.1 225.6 257.2 287.9 150.5 181.7 222.6 249.2 269.8 284.3 304.3 320.5 159.2 100.1 100.1
Total Assets 487.1 508.1 511.5 513.1 519.4 534.0 374.1 374.4 382.9 404.7 421.1 272.4 284.5 309.3 324.0 310.9 320.9 337.0 351.5 190.6 0 126.0
Total Debt 51.7 51.6 78.9 79.4 79.8 80.2 80.6 81.0 81.4 79.2 79.7 80.8 80.0 77.3 76.6 53.6 53.9 54.1 54.3 54.5 0 54.8
Stockholders' Equity 347.7 365.9 380.3 385.8 389.2 402.2 241.2 251.8 264.0 280.8 299.4 155.9 173.1 197.1 220.8 239.2 252.8 267.1 283.3 (206.3) 61.0 (182.9)
Cash Flow
Operating Cash Flow (38.1) (10.3) (6.6) (15.0) (17.0) (32.4) (18.8) (15.7) (32.3) (24.8) (18.9) (28.3) (35.9) (25.2) (19.9) (17.1) (18.2) (16.5) (12.8) (12.9) (15.2) (13.4) (10.9) (12.0) (12.0)
Capital Expenditure (2.9) (1.9) (2.9) (2.8) (1.8) (1.2) (0.2) (1.0) (1.9) (8.7) (5.8) (5.4) (5.3) (0.9) (1.5) (0.2) (0.1) (0.3) (0.1) (0.1) (0.0) (0.0) (0.0) (0.1) (0.1)
Free Cash Flow (41.0) (12.2) (9.5) (17.8) (18.8) (33.6) (19.0) (16.8) (34.2) (33.5) (24.7) (33.7) (41.3) (26.0) (21.4) (17.3) (18.3) (16.8) (12.9) (13.0) (15.2) (13.5) (11.0) (12.1) (12.1)